Graduate School and University Center Archives Finding Aid - Record Group VIII: Doctoral Students' Council

This is part of the finding aid to the Graduate School and University Center (GSUC) Archives. Record Group VIII is the files from the Doctoral Students' Council (DSC).

A atividade do British Council na area de aperfeiçoamento educacional no que se refere a treinamento de brasileiros na Grã-Bretanha e subsequente avaliação de resultados: um estudo de caso

Esta pesquisa tem por objetivo examinar as atividades do British Council no que concerne ao intercâmbio cultural de brasileiros, como também, verificar os resultados dos programas de treinamento realizados sob os níveis de reação, comportamento no cargo e organizacionaL baseando-se nas teorias de Anthony Hamblin.

Adjuvant therapy with GnRH agonists/tamoxifen in breast cancer should be a good council for patients with hormone receptor-positive tumours and wish to preserve fertility

Infertility represents one of the main long-term consequences of the chemotherapy used for the adjuvant treatment of breast cancer. Approximately 60-65% of breast cancers express the nuclear hormone receptor in premenopausal women. Adjuvant endocrine therapy is an integral component of care for patients with hormone receptor-positive (HR+) tumours. The GnRH agonist (GnRHa) alone or in combination with tamoxifen produces results at least similar to those obtained with the different chemotherapy protocols in patients with HR+ breast cancer with respect to recurrence-free survival and overall survival. It is time to indicate adjuvant therapy with GnRHa associated with tamoxifen for patients with breast cancer (HR+ tumours) if they want to preserve their reproductive function. The evaluation of ovarian reserve tests: follicle stimulating hormone (FSH), anti-Mullerian hormone (AMH), inhibin B, antral follicle count (AFC) and ovarian volume 6 months, and 1 year after the end of therapy with GnRHa/tamoxifen must be realised. The recurrence-free survival and overall survival should be analysed. The major implication of this hypothesis will be to avoid adjuvant chemotherapy for patients with breast cancer (HR+ tumours) that request fertility preservation. It is expected that ovarian function should not be altered in almost all cases and subsequent pregnancy a real possibility. (C) 2012 Elsevier Ltd. All rights reserved.